Guidelines for breast cancer treatment during COVID-19 pandemic

During the COVID-19 pandemic, new guidelines for treatment of beast cancer  and radiotherapy have recommend using TARGIT-IORT because it would save patients the daily travel (and viral exposure) to radiotherapy departments:

Global radiation oncology's targeted preparedness for COVID-19  

https://www.sciencedirect.com/science/article/pii/S2405630820300227 

“where the technology is available the use of IORT may obviate the need for any further outpatient treatment and should be considered an option ..” 

 

British Association of Cancer Surgery (BASO~ACS) https://baso.org.uk/media/98159/covid_19_and_breast_cancer_march_2020.pdf

German University Hospitals 

https://ro-journal.biomedcentral.com/articles/10.1186/s13014-020-01527-1

Italian Association of Radiotherapy and Clinical Oncology

https://www.thegreenjournal.com/article/S0167-8140(20)30221-8/fulltext

China is increasing its use of TARGIT-IORT #breastcancer by equipping more centres with the TARGIT-IORT equipment 

 

 

Click here to see the national and international guidelines recommending TARGIT-IORT for breast cancer

Follow us

  • Facebook - White Circle
  • Twitter - White Circle